- Treatment patterns of prostate cancer with bone metastasis in Beijing: A real坼world study using data from an administrative claims databaseYinchu, Cheng; Lin, Zhuo; Yuting, Pan; Shengfeng, Wang; Jihong, Zong; Wentao, Sun; Shuangqing, Gao; Jian, Lu; Siyan, ZhanPharmacoepidemiology and Drug Safety, 2019, 28(11): 1501-1509.Cited by 2
- PATTERNS OF CLINICAL MANAGEMENT AND RESOURCE UTILIZATION FOR POSTMENOPAUSAL HORMONE RECEPTOR-POSITIVE HER2-NEGATIVE (HR+HER2-) ADVANCED BREAST CANCER (ABC) IN EUROPEAndre F; Marinsek N; Ricci J F; Etchberger J; Degun R; Benelli G; Saletan S; Jerusalem G
- Plasma cell-free DNA-based predictors of response to abiraterone acetate/prednisone and prognostic factors in metastatic castration-resistant prostate cancerMeijun, Du; Yijun, Tian; Winston, Tan; Liewei, Wang; Liguo, Wang; Deepak, Kilari; Chiang-Ching, Huang; Liang, Wang; Manish, KohliPROSTATE CANCER AND PROSTATIC DISEASES, 2020, 23(4): 705-713.Cited by 2
Conference paper
REAL-WORLD TREATMENT PATTERNS (TXP) AND HEALTHCARE RESOURCE UTILIZATION (HRU) IN PATIENTS WITH NONMETASTATIC CASTRATIONRESISTANT PROSTATE CANCER (NMCRPC) AND METASTATIC HORMONE-SENSITIVEPROSTATE CANCER (MHSPC) IN CHINA
9Reads
